KAI has an in-house full service statistics group with experience in designing and
writing protocols and statistical plans; designing and implementing sampling statistics
and randomization procedures; carrying out interim and final analysis of the data.
They contribute to the writing of clinical study reports and provide results for
submission to the FDA. KAI's staff comprising this group has backgrounds in the
pharma industry, NIH and academia.
In addition KAI has developed a battery of SAS programs and macros that can be used
to produce statistical reports, listings and tabulations that are customarily included
in IND, NDA and BLA submissions to the FDA, and in support of DSMB meetings. These
SAS programs can be quickly implemented to keep programming development time down
and get submission ready output to the client.
|
